All times listed are Pacific Standard Time
​
8 Total CME Hours
Wednesday, April 7, 2021- 4 hours of CME
12:00pm – 12:15pm          
Welcome, Jashin Wu, M.D.

12:15pm – 12:45pm          
Basal Cell Carcinoma: Updates and Surgical Treatment Considerations, Suzanne Olbricht, M.D., F.A.A.D.

12:45pm – 1:15pm            
Non-surgical Treatments for BCC and Decision-making Conundrums, Suzanne Olbricht, M.D., F.A.A.D.

1:15pm – 1:45pm              
Squamous Cell Carcinoma Overview and Tough Mohs Surgery Cases, Daniel Siegel, M.D., F.A.A.D.

1:45pm – 2:15pm              
Medical Treatment of Squamous Cell Carcinoma, Daniel Siegel, M.D., F.A.A.D.

2:15pm – 3:00pm              
TBD product theater

3:00pm – 3:30pm              
Merkel Cell Carcinoma, Siegrid Yu, M.D., F.A.A.D.

3:30pm – 4:00pm              
Dermatofibrosarcoma Protuberans, Siegrid Yu, M.D., F.A.A.D.

4:00pm– 4:30pm               
CTCL Diagnosis, Staging, and Topical Therapy, Joan Guitart, M.D., F.A.A.D.

4:30pm – 5:00pm              
CTCL Chemotherapy for the Dermatologist, Joan Guitart, M.D., F.A.A.D.

5:00pm – 5:45pm              TBD product theater


Thursday, April 8, 2021 - 4 hours of CME
11:30am – 12:15pm          
TBD product theater

12:15pm – 12:45pm          
Actinic Keratosis, Ted Rosen, M.D., F.A.A.D.

12:45pm – 1:15pm            
Actinic Keratosis Treatments, Ted Rosen, M.D., F.A.A.D.

1:15pm – 2:15pm              
Dermoscopic Features of Nevi and Melanoma, Ashfaq A. Marghoob, M.D., F.A.A.D.

2:15pm – 3:00pm              
TBD product theater

3:00pm – 3:30pm              
Melanoma Diagnosis, Staging, and Prognosis, Laura Ferris, M.D., Ph.D., F.A.A.D.

3:30pm – 4:00pm              
Melanoma Immunotherapy for the Dermatologist, Laura Ferris, M.D., Ph.D., F.A.A.D.

4:00pm – 4:30pm              
Dermatopathology of Melanoma, Clay Cockerell, M.D., F.A.A.D.

4:30pm – 5:00pm              
Dermatopathology of Adnexal Tumors and Other Rare Skin Cancers, Clay Cockerell, M.D., F.A.A.D.

5:00pm – 5:45pm              
TBD product theater

5:45pm – 5:50pm              
Conference closing, Jashin Wu, M.D.